Sigma Planning Corp - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 20 filers reported holding MEDICENNA THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$187,129
+27.2%
634,550
+107.8%
0.01%
+40.0%
Q2 2023$147,063
-22.7%
305,300
+1.1%
0.01%
-16.7%
Q1 2023$190,171
+37.2%
302,050
-0.2%
0.01%
+20.0%
Q4 2022$138,568
-36.4%
302,550
+15.0%
0.01%
-37.5%
Q3 2022$218,000
-25.3%
263,050
+4.4%
0.01%
-20.0%
Q2 2022$292,000
+14.1%
252,050
+25.8%
0.01%
+25.0%
Q1 2022$256,000
+12.3%
200,300
+43.0%
0.01%
+33.3%
Q4 2021$228,000
+171.4%
140,050
+359.2%
0.01%
+100.0%
Q3 2021$84,00030,5000.00%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,346,983$2,759,9511.02%
Worth Venture Partners, LLC 1,053,808$684,9750.33%
DAFNA Capital Management LLC 660,000$415,5360.12%
Annandale Capital, LLC 40,000$260.01%
Sigma Planning Corp 302,050$190,1710.01%
Hudson Bay Capital Management LP 1,648,094$1,071,2620.01%
Verition Fund Management LLC 603,407$392,2150.01%
McKinley Carter Wealth Services, Inc. 79,259$49,9020.00%
Newman Dignan & Sheerar, Inc. 12,915$8,1310.00%
Patriot Financial Group Insurance Agency, LLC 19,400$12,2140.00%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders